# Galen Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/galen-robotics

- Industry: Medical Devices & Equipment
- Headquarters: Baltimore, US
- Website: www.galenrobotics.com
- Total disclosed funding: $15M
- Latest round: Series A (Nov 1, 2022)
- Investors on record: 1

## About

Galen Robotics, Inc. is a US-based medical technology company specializing in surgical automation solutions that enhance precision and efficiency in surgical procedures across various medical fields.Founded in 2016 and headquartered in Baltimore, US, Galen Robotics, Inc. focuses on developing advanced robotic systems for surgical assistance. The company has not reported any significant pivots or changes in its business strategy since its inception. The latest funding round, which occurred on June 27, 2023, raised USD 500,000 from the Maryland Technology Development Corporation, bringing the total amount raised to USD 500,000. This funding serves to support the company's ongoing technology development efforts.Galen Robotics offers a core product known as the Galen Platform, a cooperative surgical assist device designed to enhance surgical procedures across various medical fields, including neurosurgery, otolaryngology, tissue reconstruction, intrauterine brain, and spine surgery. This system is engineered to work in conjunction with standard surgical instruments, significantly improving stability and ergonomics during narrow corridor and minimally invasive surgeries. The Galen Platform aims to democratize access to advanced surgical technologies, making it particularly valuable to local community hospitals and ambulatory surgical centers (ASCs). By focusing on a model that minimizes upfront costs and emphasizes ease of integration with existing surgical practices, the Galen Platform targets healthcare providers in North America, Europe, and select markets in Asia.Galen Robotics operates on a revenue model that emphasizes a 'Surgery-as-a-Service' approach, allowing healthcare providers to access the Galen Platform through usage-based pricing rather than traditional capital purchases. This model facilitates a transaction structure centered around per-patient pricing, enabling hospitals and ASCs to utilize the technology based on their specific procedural needs without incurring significant upfront costs. The company’s offerings may include subscription plans and service agreements that cover maintenance and support, ensuring continuous access to the latest innovations in surgical robotics. Transactions typically occur directly between Galen Robotics and healthcare providers, allowing for tailored solutions that can be adjusted according to the surgical procedures being performed. The end-users of the Galen Platform are surgeons and medical professionals who benefit from enhanced surgical capabilities, ultimately leading to improved patient outcomes and satisfaction.The most recent funding of USD 500,000 raised in June 2023 will be utilized to further develop Galen Robotics' technological capabilities. The company is currently focusing on enhancing the Galen Platform with new features aimed at improving surgical outcomes and ease of use. Additionally, Galen Robotics plans to expand into new geographic regions, specifically targeting markets in Europe and Asia in the next 1 to 2 years to increase its global footprint.

## Funding rounds

- Series A, Nov 1, 2022, $15M — Ambix Ventures

## Investors

- Ambix Ventures (https://capitalatlas.ai/funds/ambix-ventures) — Series A